Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases

US5849799A · kind A · utility

Assignee

• Behringwerke Aktiengesellschaft · DE

Inventors

• Jürgen Lindner · Worms, DE
• Gerhard Dickneite · Marburg, DE
• Hans-Ulrich Schorlemmer · Marburg, DE
• Klaus Bosslet · Marburg, DE

Key dates

• Filing date: Mar 20, 1995
• Grant date: Dec 15, 1998
• Expiry date: Mar 20, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P37/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods are disclosed for treatment of hyperreactive inflammatory diseases of humans and animals comprising administering a pharmaceutically effective amount of deoxyspergualin to a human or an animal.